Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.Vertex Pharmaceuticals ( VRTX) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 1.0%. By the end of trading, Vertex Pharmaceuticals rose $1.86 (2.5%) to $76.53 on light volume. Throughout the day, 1,532,839 shares of Vertex Pharmaceuticals exchanged hands as compared to its average daily volume of 2,199,300 shares. The stock ranged in a price between $74.34-$76.59 after having opened the day at $74.67 as compared to the previous trading day's close of $74.67. Other companies within the Health Care sector that increased today were: GW Pharmaceuticals PLC ADR ( GWPH), up 75.8%, Opexa Therapeutics ( OPXA), up 17.0%, Cardiome Pharma Corporation ( CRME), up 16.4% and Receptos ( RCPT), up 14.2%.
Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. Vertex Pharmaceuticals has a market cap of $17.4 billion and is part of the drugs industry. Shares are up 77.9% year to date as of the close of trading on Wednesday. Currently there are 12 analysts that rate Vertex Pharmaceuticals a buy, no analysts rate it a sell, and 7 rate it a hold. TheStreet Ratings rates Vertex Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share.